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Abstract
Background: Pregnancy is a time of altered metabolic functioning and maternal blood lipid profiles change to
accommodate the developing fetus. While these changes are physiologically necessary, blood lipids concentrations
have been associated with adverse pregnancy outcomes such as gestational diabetes, pregnancy-induced hypertension
and high birth weight. As blood lipids are not routinely measured during pregnancy, there is limited information on what
is considered normal during pregnancy and in fetal blood.
Methods: Data from 327 mother-child pairs from the ROLO longitudinal birth cohort study were analysed. Fasting total
cholesterol and triglycerides were measured in early and late pregnancy and fetal cord blood. Intervals were calculated
using the 2.5th, 50th and 97.5th centile. Data was stratified based on maternal body mass index (BMI) measured during
early pregnancy. Differences in blood lipids between BMI categories were explored using ANOVA and infant outcomes
of macrosomia and large-for-gestational-age (LGA) were explored using independent student T-tests and binary logistic
regression.
Results: All maternal blood lipid concentrations increased significantly from early to late pregnancy. In early pregnancy,
women with a BMI < 25 kg/m2 had lower concentrations of total cholesterol compared to women with a BMI of 25–29.
9 kg/m2 (P = 0.02). With triglycerides, women in the obese category (BMI > 30 kg/m2) had higher concentrations than
both women in the normal-weight and overweight category in early and late pregnancy (P < 0.001 and P = 0.03,
respectively). In late pregnancy, triglyceride concentrations remained elevated in women in the obese category
compared to women in the normal-weight category (P = 0.01). Triglyceride concentrations were also elevated in late
pregnancy in mothers that then gave birth to infants with macrosomia and LGA (P = 0.01 and P = 0.03, respectively).
Conclusion: Blood lipid concentrations increase during pregnancy and differ by maternal BMI. These intervals could
help to inform the development of references for blood lipid concentrations during pregnancy.
Trial registration: ROLO Study - ISRCTN54392969. Date of registration: 22/04/2009.
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Background
Pregnancy is a unique physiological state that results in
alterations in the mother’s metabolic functioning. These
alterations ensure that both the mother and fetus have
adequate energy stores throughout pregnancy, and
ensure appropriate development of the fetus. As the
fetoplacental unit requires glucose, amino acids and
lipids throughout pregnancy, the mother’s metabolism
must adapt to ensure that this supply is met. These ad-
aptations influence maternal blood lipid concentrations
and during pregnancy mothers often enter a
physiologically-normal state of hyperlipidemia [1–3].
After delivery, lipid concentrations return to pre-
pregnancy concentrations which suggests that this rise
in blood lipids could play a role in the physiology of the
pregnancy and the development of the fetus [3].
However, raised blood lipid concentrations, above
those considered normal during pregnancy, have been
associated with negative health outcomes for both the
mother and the child. Research suggests that early-
pregnancy lipid profiles, particularly elevated total chol-
esterol and triglyceride concentrations, may be used to
identify those at increased risk of developing gestational
diabetes [4–6]. Elevated triglyceride concentrations have
also been associated with increased risk of pregnancy-
induced hypertension and pre-eclampsia in a European
cohort [7]. Research has also shown that metabolic
changes in pregnancy may be related to the composition
of lipids and lipoproteins [8]. This may influence the flux
of lipids to the placenta which may, in turn, alter fetal
lipid concentrations.
In relation to infant outcomes, maternal triglycerides
have been positively associated with fetal size, birth weight
and fat mass [9]. Higher total cholesterol and triglyceride
concentrations have been associated with higher birth
weight [10], increased risk of large-for-gestational age
(LGA) [7, 11], and pre-term delivery [7]. However, the
point at which maternal blood lipid concentrations
become problematic for maternal and infant health out-
comes is unclear. One study examined associations of ma-
ternal total cholesterol concentrations and fetoplacental
endothelial dysfunction and cited above the 75th percent-
ile value (7.5 mmol/L) in their cohort as abnormal, based
on observations of endothelial dysfunction above this con-
centration [12]. There is potential for the use of maternal
triglyceride concentrations as predictive factors for LGA
births in women with gestational diabetes [13].
Additionally, there is a paucity of data available on
fetal blood lipid concentrations. One study identified
lipid profiles that differed in small-for-gestational-age
infants compared to normal-weight infants, with
increased levels of apo C-I–enriched high-density li-
poproteins [14], however information is still lacking
in this area. Maternal lipid concentrations have been
correlated with fetal lipid concentrations at birth
among women with diabetes, which highlights the im-
portance of the maternal environment on the fetus
during pregnancy [9].
Recommended blood lipid concentrations are available
for non-pregnant individuals; below 5 mmol/L for total
cholesterol and below 2 mmol/L for triglycerides [15].
However, there are currently no recommended intervals
available for maternal blood lipid concentrations during
pregnancy or for fetal blood. Thus, the aim of this paper
was to address this knowledge-deficit by describing
blood lipid concentrations in our cohort of healthy
women with singleton pregnancies without gestational
diabetes or pre-eclampsia. While these women had all
previously given birth to macrosomic infants, the cohort
had no complications during pregnancy. As research has
shown that blood lipid concentrations differ by maternal




A group of 327 mother and child dyads with blood
lipid measurements available from during pregnancy
from the ROLO (Randomised cOntrol trial of LOw
glycaemic index diet) study were included in this ana-
lysis. The original study involved 800 secundigravida
women, whose first baby had a birth weight above
4 kg, randomised to either a low glycaemic index diet
during pregnancy or routine antenatal natal care with
no specific dietary advice. This study was carried out
in The National Maternity Hospital, Dublin, Ireland,
with institutional ethical approval and maternal writ-
ten consent. Trial registration number for the ROLO
study is ISRCTN54392969. Detailed methods and
results of the ROLO study have previously been pub-
lished [18–20]. In brief, the intervention involved one
dietary education session (and two follow-up meetings
at 28 and 34 weeks’ gestation) with a research
dietitian where the women were educated about the
glycaemic index and encouraged to follow a low
glycaemic index diet. The recommended diet was
eucaloric and the women were not advised to reduce
their total energy intake. The intervention did not in-
fluence birth weight, however, mothers in the inter-
vention group had significantly less gestational weight
gain and improved glucose tolerance [21]. The inter-
vention had no impact on maternal or fetal blood
lipid profiles so all participants are analysed together
in this analysis. The women included all had healthy,
full-term singleton pregnancies; there were no adverse
maternal outcomes in pregnancy, such as gestational
diabetes or pre-eclampsia, and no pre-term births.
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Data collection
Height and weight were measured by trained profes-
sionals in early pregnancy (at 13 weeks’ gestation, as cal-
culated based on the participant’s last menstrual period
and first trimester ultrasound) in the hospital, and BMI
(kg/m2) was calculated. Maternal overnight fasting blood
samples were taken in early pregnancy and late preg-
nancy (at 28 weeks’ gestation) and a fetal cord blood
serum sample was collected at delivery. Birth weight was
recorded at delivery along with incidence of macrosomia
(birth weight of or above 4 kg) and LGA, which was
classified as birth weight above the 90th centile (taking
into account gestational age and sex).
Laboratory analyses
Serum total cholesterol was measured using Roche
cholesterol oxidase method and triglyceride concen-
trations were measured using the lipase/GPO-PAP
(glycerol phosphate oxidase-p-aminophenazone). All
measurements were carried out on the cobas c702
module of the Roche Cobas 8000 analyser in accor-
dance with the manufacturer’s instructions (Roche
Diagnostics GmbH, Penzburg, Germany). The
methods are standardised against the isotope dilution/
mass spectrometry (ID/MS) methods.
Statistical analyses
All variables were evaluated for normal distribution by
visual analysis of histograms and non-normal data
underwent logarithmic transformation. Antilogarithms
were used in the presentation of the results, where re-
quired. Intervals were calculated using the 2.5th, 50th
and 97.5th centile for the total group and for each BMI
category; BMI < 25 kg/m2, BMI 25–29.9 kg/m2 and
BMI ≥ 30 kg/m2. Differences between the central
tendencies in these categories were examined using one-
way ANOVA or Chi-square tests, as appropriate. Corre-
lations between blood lipid concentrations are each time
point was examined using Pearson correlation for
normally distributed data and Spearman’s correlation for
non- normal data. Differences in blood cholesterol and
triglycerides based on birth outcomes of macrosomia
and LGA were examined using independent sample t-
tests, and binary logistic regression was carried out to
investigate the association of maternal BMI on this.
Statistical analyses were carried out using SPSS (Statis-
tical Package for the Social Sciences) software version
20.0 (IBM, Armonk, NY).
Results
Cohort characteristics
Mean BMI at 13 weeks’ gestation was 26.4 kg/m2, which
is in the overweight category (Table 1). Just over half
(54.4%) of the study participants had a BMI ≥ 25 kg/m2.
Mean infant birth weight was 4.06 kg with 54.7% of in-
fants classified as macrosomic and 29.3% as LGA. Mean
birth weight centile was 72.9. There was a significant
difference in birth weight with babies born to mothers
with a BMI ≥ 25 kg/m2 having a higher birth weight
than those born to mothers with a BMI < 25 kg/m2
(P = 0.02).
The intervals for maternal blood lipids in early and
late pregnancy and for fetal cord blood concentrations
are described for the total group and each maternal BMI
category (Table 2). Both total cholesterol and triglyceride
concentrations increased significantly from early preg-
nancy to late pregnancy (P < 0.001). The median con-
centrations of total cholesterol in early pregnancy, for
the total group and each BMI category, are within the
recommendations for non-pregnant individuals, below
5 mmol/L, however by late pregnancy 67.7% of the
participants exceeded this concentration. The median
Table 1 Characteristics of mothers and infants from the ROLO Cohort
Total (n = 327) BMI < 25 (n = 149) BMI 25–29.9 (n = 127) BMI ≥ 30 (n = 51) P-value
Maternal Characteristics
Age at delivery (years) 33.10 (3.90) 33.44 (3.75) 32.80 (4.10) 32.59 (3.91) 0.29
BMI at 13 weeks’ gestation (kg/m2) 26.40 (4.60) 22.83 (1.61) 27.11 (1.40) 34.77 (3.65) –
Achieved 3rd level education (n(%)) 174 (58.6) 83 (61.0) 71 (55.0) 18 (40.0) 0.03*
Smoked during pregnancy (n(%)) 7 (2.1) 0 (0) 6 (4.7) 1 (2) 0.03*
Ethnicity (Caucasian) (n(%)) 323 (98.8) 147 (98.6) 127 (100) 50 (98.0) 0.66
Neonatal/Infant Characteristics
Male sex (n(%)) 157 (47.4) 74 (49.7) 57 (44.2) 25 (49) 0.64
Gestational age at delivery (weeks) 40.4 (1.07) 40.33 (1.07) 40.49 (0.98) 40.40 (1.32) 0.51
Birth weight (kg) 4.07 (0.47) 4.00 (0.47) 4.13 (0.44) 4.10 (0.55) 0.07
Birth weight centile 72.90 (24.9) 74.36 (25.65) 74.27 (22.26) 64.91 (27.91) 0.06
All data expressed as either mean (SD) or n (%) for available data on cohort, BMI Body mass index. Statistical comparisons by one-way ANOVA or Chi-square
tests. *P < 0.05
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concentrations for triglycerides in early and late pregnancy
are both in-line with the recommendations for a non-
pregnant cohort, however, while in early pregnancy 3.9% of
the cohort had triglyceride concentrations >2 mmol/L, this
increases to 30% in late pregnancy. Early pregnancy choles-
terol and triglyceride concentrations were not associated
with fetal concentrations, however, in late pregnancy, both
total cholesterol and triglyceride concentrations were posi-
tively associated with fetal total cholesterol and triglyceride
concentrations (P = 0.02 and P = 0.04, respectively).
There were significant differences in blood lipid
concentrations between the BMI categories during
pregnancy. In early pregnancy, women in the normal-
weight category (BMI <25 kg/m2) had lower concentrations
of total cholesterol compared to women in the overweight
category (BMI 25–29.9 kg/m2) (P = 0.02). Women in the
obese category (BMI > 30 kg/m2) had higher concentra-
tions of triglycerides in early pregnancy than both women in
the normal-weight and overweight categories (P < 0.001
and P = 0.03, respectively). In late pregnancy, while total
cholesterol concentrations didn’t differ significantly be-
tween the groups, triglyceride concentrations remained ele-
vated in women in the obese category compared to
women in the normal-weight category only (P = 0.005).
There were no differences in triglyceride concentrations be-
tween the overweight and obese categories in late preg-
nancy. There were also no differences between the cord
blood lipid concentrations of infants born to mothers in
the normal-weight, overweight or obese categories.
Infant size was associated with triglyceride concentrations
in late pregnancy in this cohort (see Fig. 1). Triglyceride
concentrations were higher in mothers who had a macroso-
mic baby (1.84 mmol/L vs. 1.63 mmol/L, P = 0.01). In cases
of LGA infants, triglycerides in late pregnancy were also
higher (1.86 mmol/L vs. 1.66 mmol/L, P = 0.025). On bin-
ary logistic regression, after adjustment for maternal BMI
category, triglyceride levels in late pregnancy remained as-
sociated with an increased risk of macrosomia (OR: 1.49,
CI: 1.05–2.13) and LGA (OR: 1.61, CI: 1.09–2.38). There
were no differences in any other blood lipids related to
incidence of macrosomia or LGA. Neonatal sex had no
association with maternal or fetal lipid concentrations.
Discussion
Maternal blood cholesterol and triglyceride concentra-
tions increased as pregnancy progressed in this
cohort. During pregnancy, maternal blood volume
increases by up to 45% (21) and we observed that
maternal lipid concentrations increase above this,
resulting in a hyperlipidemic state. In addition, mater-
nal weight was associated with blood lipid concentra-
tions as a higher BMI was associated with higher
concentrations of total cholesterol in early pregnancy,
and triglycerides in early and late pregnancy.
Our results are in accord with previous studies that
have shown that blood lipid concentrations increase dur-
ing pregnancy, with cholesterol concentrations estimated
to increase by up to 70% compared to pre-pregnancy
concentrations [3, 16, 22–24]. Compared to non-
pregnant women, triglyceride concentrations in late
pregnancy may be up to 138% higher [3]. While blood
lipid concentrations after pregnancy were not available
in this cohort, other research has indicated that lipid
concentrations return to pre-pregnancy concentrations
after delivery, suggesting that the increase in blood lipids
could have an important role in the development of the
Table 2 Blood lipid Intervals during early and late pregnancy by maternal BMI category
Early Pregnancy (13 weeks’ gestation)
Total Group (n = 284) BMI < 25 (n = 136) BMI 25–29.99 (n = 104) BMI ≥ 30 (n = 42)
Percentile 2.5 50 97.5 2.5 50 97.5 2.5 50 97.5 2.5 50 97.5
Total cholesterol 1.75 4.58 6.73 1.59 4.29 6.69 1.67 4.80 6.92 1.77 4.65 6.31
Triglycerides 0.35 1.03 2.12 0.29 0.94 2.02 0.37 1.07 2.13 0.37 1.32 2.54
Late Pregnancy (28 weeks’ gestation)
Total Group (n = 293) BMI < 25 (n = 136) BMI 25–29.9 (n = 114) BMI ≥ 30 (n = 41)
Percentile 2.5 50 97.5 2.5 50 97.5 2.5 50 97.5 2.5 50 97.5
Total cholesterol 2.1 6.02 8.61 1.83 6.06 8.82 2.41 6.11 8.57 1.97 5.63 8.50
Triglycerides 0.58 1.71 3.24 0.40 1.66 2.91 0.61 1.71 3.33 0.64 1.84 5.12
Fetal Cord Blood (delivery)
Total Group (n = 227) BMI < 25 (n = 97) BMI 25–29.9 (n = 96) BMI ≥ 30 (n = 33)
Percentile 2.5 50 97.5 2.5 50 97.5 2.5 50 97.5 2.5 50 97.5
Total cholesterol 1.04 1.70 3.26 1.04 1.73 3.19 1.03 1.68 3.56 0.98 1.63 -a
Triglycerides 0.24 0.46 1.45 0.20 0.46 1.38 0.24 0.44 1.51 0.29 0.54 -a
All blood lipid concentrations given in mmol/L, BMI Body Mass Index (kg/m2)
aSample size insufficient to calculate the 97.5th percentile
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fetus [3, 23, 24]. This is further supported by research
highlighting that the increase in blood lipids during
pregnancy is not associated with an increased risk of
atherosclerosis in women [3, 25]. In fact, raised HDL-C
may have a role in protecting the maternal vascular
endothelium during pregnancy [26, 27]. It is thought
that a failure of the body to increase HDL-C concentra-
tions during pregnancy may be linked with the develop-
ment of pre-eclampsia [27].
The differences we observed in triglyceride concen-
trations between the BMI categories could be an indica-
tion of altered metabolism or possibly increased levels
of insulin resistance in pregnant women with over-
weight or obesity [28]. Previous research in this cohort
reported an association between triglyceride concentra-
tions and birth weight in women in the overweight or
obese category only [29]. This highlights the import-
ance of carrying out further research to establish
normal lipid concentrations in pregnancy as these con-
centrations could indicate future risk for the women or
offspring. In our cohort there were no differences in
fetal lipid concentrations between the BMI groups.
Given that maternal concentrations, but not fetal blood
lipid concentrations, differed by maternal BMI, this
raises an interesting question as to the role of the pla-
centa as a potential mediator. Research has shown that
the composition of particular lipoproteins may influ-
ence the flux of lipids to the placenta which may play a
mechanistic role here [30]. Further research on lipid
concentrations in fetal blood may be required to estab-
lish normal levels and the physiological implications of
abnormal values.
Other studies have reported different blood lipid profiles
and metabolic responses in mothers in the normal-weight
and overweight or obese categories [17]. One such study
found that women in the overweight or obese category had
higher baseline cholesterol and triglyceride concentrations
compared to women in the normal-weight category; how-
ever, in later pregnancy the women in the normal-weight
category had higher total cholesterol concentrations as their
weekly concentrations increased at a faster rate during preg-
nancy [16]. This is comparable to our findings where women
in the normal-weight and overweight categories had similar
total cholesterol concentrations in late pregnancy, despite
higher concentrations among overweight/obese categories
in early pregnancy. Recently published research has
also highlighted how energy metabolism during preg-
nancy differs between women in overweight and
normal-weight BMI categories [30]. During pregnancy
women with a BMI > 25 had higher lipid oxidation
rates than women with a BMI < 25, particularly at
the end of pregnancy [30]. This may also explain why
our total cholesterol levels in late pregnancy are more
similar between the two groups as the mothers in
the overweight category may have had higher lipid
oxidation rates at this stage. Published reports de-
scribing maternal blood lipids in pregnancy have
largely focused on women with gestational diabetes or
glucose intolerance [5, 6]. To date, studies relating
alterations in blood lipid concentrations during non-
diabetic pregnancy have had sample sizes below the
120 recommended by the Clinical and Laboratory
Standards Institute [31], or have used values based on
just one time point [8, 22, 23].
Fig. 1 Maternal triglyceride concentrations in late pregnancy in macrosomic neonates (>4 kg weight) or large-for-gestational-age (>90th centile)
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This analysis had many strengths in that there was a
large number of participants in the total study and blood
samples were collected in both early and late pregnancy,
which can help us understand normal changes over the
course of a pregnancy. Blood lipid profiles were also
analysed in fetal blood and there is currently a paucity of
data in this area. To our knowledge, this is one of the
few studies to create lipid reference intervals during
pregnancy and to categorise them by BMI, which adds
to this body of literature. There were some limitations
that must be taken into account. In this cohort, 54.7% of
the babies were classified as macrosomic and 29.3% as
LGA so this may not be representative of the entire
population, however these mothers were healthy with no
pregnancy complications. There were also a small num-
ber of participants in the obese category (BMI ≥30 kg/
m2), thus the 97.5th percentile could not be calculated
for the fetal cord samples in this group.
With maternal blood lipid profiles in pregnancy being
associated with both maternal and child outcomes, it
may be advisable to monitor blood lipid concentrations
in pregnant women to identify both normal concentra-
tions during pregnancy and the levels at which lipid con-
centrations become problematic. This could potentially
be used to identify concentrations associated with in-
creased risks of adverse outcomes in pregnancy, particu-
larly abnormal fetal growth, and allow for early
interventions to prevent negative outcomes for the
mother or infant. Given that there was no difference in
fetal concentrations between the BMI categories but
there was in maternal concentrations, the potential me-
diating role of the placenta and the influence of blood
lipid composition in limiting lipid transfer also remains
to be explored.
Conclusion
Maternal blood lipid concentrations increase over the course
of pregnancy and the concentrations at which this can nega-
tively impact both the health of the mother and the child re-
mains to be elucidated. We described intervals in healthy
women for total cholesterol and triglyceride concentrations
during pregnancy, and also in fetal cord blood. We found
that maternal cholesterol and triglyceride concentrations dif-
fer by BMI category which may indicate altered metabolic
functioning. Blood lipid concentrations are associated with
negative outcomes for the mother and infant, thus these in-
tervals can help to inform future references for blood lipid
concentrations throughout pregnancy.
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